Letybo (Letibotulinumtoxina-Wlbg) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Letybo. Always confirm against the full prescribing information.
89 interactions
Atracurium besylate
The risk or severity of neuromuscular blockade can be increased when Atracurium besylate is combined with Letibotulinumtoxina.
Level 2 evidence
Baclofen
The therapeutic efficacy of Letibotulinumtoxina can be increased when used in combination with Baclofen.
Level 1 evidence
Beclomethasone dipropionate
The risk or severity of myopathy and weakness can be increased when Letibotulinumtoxina is combined with Beclomethasone dipropionate.
Level 2 evidence
Betamethasone
The risk or severity of myopathy and weakness can be increased when Letibotulinumtoxina is combined with Betamethasone.
Level 2 evidence
Botulinum toxin type A
The risk or severity of neuromuscular blockade can be increased when Botulinum toxin type A is combined with Letibotulinumtoxina.
Level 2 evidence
Botulinum toxin type B
The therapeutic efficacy of Letibotulinumtoxina can be increased when used in combination with Botulinum toxin type B.
Level 1 evidence
Budesonide
The risk or severity of myopathy and weakness can be increased when Letibotulinumtoxina is combined with Budesonide.
Level 2 evidence
Chloroquine
The therapeutic efficacy of Letibotulinumtoxina can be increased when used in combination with Chloroquine.
Level 1 evidence
Ciclesonide
The risk or severity of myopathy and weakness can be increased when Letibotulinumtoxina is combined with Ciclesonide.
Level 2 evidence
Cisatracurium
The risk or severity of neuromuscular blockade can be increased when Cisatracurium is combined with Letibotulinumtoxina.
Level 2 evidence
Clindamycin
The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Letibotulinumtoxina.
Level 1 evidence
Clobetasol propionate
The risk or severity of myopathy and weakness can be increased when Letibotulinumtoxina is combined with Clobetasol propionate.
Letybo (Letibotulinumtoxina-Wlbg) has 89 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Letybo (Letibotulinumtoxina-Wlbg) has 0 major, 87 moderate, and 2 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Letybo. Always confirm against the full prescribing information.